P072: Impact of Ageing on the Survivorship Experiences of Patients with Hodgkin Lymphoma

P072: Impact of Ageing on the Survivorship Experiences of Patients with Hodgkin Lymphoma

Bibliographic Details
Main Authors:	Cherie Bates, Funmi Bamigbola, Lorna Warwick
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000890856.23828.de

Similar Items

P1701: A COMPARATIVE STUDY OF THE IMPACT OF COUNTRIES’ HEALTH EXPENDITURE ON THE DIAGNOSIS EXPERIENCES OF PATIENTS WITH LYMPHOMA AND CLL IN EUROPE
by: F. Bamigbola, et al.
Published: (2022-06-01)

P049 (0072) RESULTS OF CARDIOVASCULAR SCREENING IN THE BETER SURVIVORSHIP CARE INITIATIVE FOR HODGKIN LYMPHOMA
Published: (2018-10-01)

P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands
by: Eline M.J. Lammers, et al.
Published: (2022-10-01)

P.072 THE DIFFERENTIATION IN THE CONTRIBUTION OF VASCULAR AND CEREBRAL SEGMENTS TO BRS
by: N.P. Saeed*, et al.
Published: (2007-06-01)

072 WORSENING RENAL FUNCTION IN HEART FAILURE PATIENTS
by: M.H. Tan, et al.
Published: (2017-08-01)

P072 (0038) FRONTLINE BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY EXHIBITS SUPERIOR MODIFIED PROGRESSION-FREE SURVIVAL VS CHEMOTHERAPY ALONE IN PATIENTS WITH STAGE III OR IV HODGKIN LYMPHOMA: PHASE 3 ECHELON-1 STUDY
Published: (2018-10-01)

EXPERIENCE IN THE TREATMENT OF REFRACTORY HODGKIN’S LYMPHOMA
by: A. M. Chervontseva, et al.
Published: (2021-03-01)

PB2671: AN INVESTIGATION INTO THE PREFERENCES OF PATIENTS REGARDING THE USE OF TELEMEDICINE STEMMING FROM THE COVID-19 PANDEMIC.
by: Steve Kalloger, et al.
Published: (2023-08-01)

P-072: COST COMPARISON OF TRANSFUSION CHOICES IN OMAN FOR PATIENTS SUFFERING FROM SICKLE CELL DISEASE.
by: AL KINDI S., et al.
Published: (2022-08-01)

P057 (0108) COGNITIVE IMPAIRMENTS IN PATIENTS WITH HODGKIN'S LYMPHOMA
Published: (2018-10-01)

P104 (0004) NIVOLUMAB IN RELAPSED/REFRACTORY CLASSIC HODGKIN LYMPHOMA: EXPERIENCE WITH TEN PATIENTS
Published: (2018-10-01)

P072: Assessing the characteristics associated with carriers of the CHEK2 S428F variant
by: Calan Szmyd, et al.
Published: (2024-01-01)

P043: Molecular pathogenesis of Hodgkin lymphoma
by: Lilian Beeck, et al.
Published: (2022-10-01)

POS-072 PRACTICAL EXPERIENCE WITH THE IMPLEMENTATION OF NGAL FOR AKI DIAGNOSIS IN A CLINICAL SETTING
by: J.M. COTE, et al.
Published: (2021-04-01)

Non-Hodgkin Lymphoma Secondary to Hodgkin Lymphoma in an Adult Patient With Nijmegen Breakage Syndrome
by: Krischan Braitsch, et al.
Published: (2018-10-01)

P042 (0035) ANEMIA HAS A NEGATIVE IMPACT ON THE OUTCOME OF PATIENTS WITH HODGKIN LYMPHOMA
Published: (2018-10-01)

P1531: TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON-HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE
by: Luca Pezzullo, et al.
Published: (2023-08-01)

P045: Plasma proteome profiling of cardiotoxicity in patients with Hodgkin lymphoma
by: Johan Mattsson Ulfstedt, et al.
Published: (2022-10-01)

Peripheral T Cell Non-Hodgkin’s Lymphoma following Treatment of Hodgkin’s Lymphoma
by: Sun Hee Chang, et al.
Published: (2015-01-01)

Composite Lymphoma: Hodgkin and Non-Hodgkin Lymphoma A Case Report
by: Noorwati Soetandyo, et al.
Published: (2018-09-01)

P.42 The Effects of Chemotherapy on Arterial Stiffness in Patients with Hodgkin Lymphoma
by: Constantinos Anagnostopoulos, et al.
Published: (2020-12-01)

P018 (0139) GATA3 EXPRESSION DISTINGUISHES CLASSIC HODGKIN LYMPHOMA FROM NODULAR LYMPHOCYTE HODGKIN LYMPHOMA
Published: (2018-10-01)

Nivolumab in relapsed/refractory Hodgkin Lymphoma patients, single center experiences
by: Ramazan Acar, et al.
Published: (2020-12-01)

Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience
by: Bouthaina Shbib Dabaja, et al.
Published: (2022-07-01)

P012 (0081) SOLUBLE CYTOKINES IN HODGKIN LYMPHOMA PATIENTS TREATED WITH A GHSG POLICY: AN ANALYSIS OF THE CZECH HODGKIN LYMPHOMA STUDY GROUP
Published: (2018-10-01)

Suicide in European Hodgkin Lymphoma Patients
by: Austin I. Kim, et al.
Published: (2019-04-01)

Pneumocystis pneumonia in patients with Hodgkin lymphoma
by: T N Moiseeva, et al.
Published: (2014-11-01)

Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma
by: Reid W. Merryman, et al.
Published: (2017-12-01)

The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy
by: David Pereg, et al.
Published: (2007-09-01)

Rare forms of non-Hodgkin lymphomas: experience in treatment for primary bone lymphomas
by: I. B. Lysenko, et al.
Published: (2020-08-01)

Macrophages in Hodgkin's lymphoma.
by: Pazianas, M
Published: (2010)

EBV IN HODGKIN LYMPHOMA
by: Giuseppina Massini, et al.
Published: (2009-11-01)

EBV IN HODGKIN LYMPHOMA
by: Stefan Hohaus, et al.
Published: (2009-11-01)

PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01)

Pathobiology of Hodgkin Lymphoma
by: Pier Paolo Piccaluga, et al.
Published: (2011-01-01)

Cutaneous Hodgkin's lymphoma
by: Asawari Anant Ambekar, et al.
Published: (2017-01-01)

NON-HODGKIN'S LYMPHOMA
by: Sajjad Ahmad Baloch
Published: (2015-01-01)

Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design
by: Eline M J Lammers, et al.
Published: (2024-04-01)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
by: Ahmet Dogan
Published: (2022-10-01)

P020 (0164) EXTRACELLULAR CIRUCULATING DNA IN HODGKINS LYMPHOMA PATIENTS: BIOLOGICAL CORELLATES AND PROGNOSTIC IMPACT
Published: (2018-10-01)